We next examined CDCP1, a protein overexpressedin RAS-driven cancers.The cleavage-specific antibody CL03 has previously been shown to localizeto tumors and exhibit antitumor activity with improved safety profiles, but it demonstrated limited internalization(Figure c) and inefficientdegradation of cCDCP1 (Figure f). This evidence concerns the gene CDCP1 and cancer.